Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Presentation, management, and outcomes of cauda equina syndrome up to one year after surgery, using clinician and participant reporting: A multi-centre prospective cohort study.
Woodfield J, Hoeritzauer I, Jamjoom AAB, Jung J, Lammy S, Pronin S, Hannan CJ, Watts A, Hughes L, Moon RDC, Darwish S, Roy H, Copley PC, Poon MTC, Thorpe P, Srikandarajah N, Grahovac G, Demetriades AK, Eames N, Sell PJ, Statham PFX; UCES Collaborators; British Neurosurgical Trainee Research Collaborative. Woodfield J, et al. Among authors: watts a. Lancet Reg Health Eur. 2022 Nov 17;24:100545. doi: 10.1016/j.lanepe.2022.100545. eCollection 2023 Jan. Lancet Reg Health Eur. 2022. PMID: 36426378 Free PMC article.
More questions than answers to the diagnosis and management of cauda equina syndrome-Authors' reply.
Woodfield J, Hoeritzauer I, Jamjoom AAB, Lammy S, Pronin S, Hannan CJ, Watts A, Hughes L, Moon RDC, Roy H, Poon MTC, Thorpe P, Srikandarajah N, Demetriades AK, Eames N, Sell PJ, Statham PFX. Woodfield J, et al. Among authors: watts a. Lancet Reg Health Eur. 2023 Mar 7;27:100606. doi: 10.1016/j.lanepe.2023.100606. eCollection 2023 Apr. Lancet Reg Health Eur. 2023. PMID: 36926263 Free PMC article. No abstract available.
Directed conservation of the world's reef sharks and rays.
Goetze JS, Heithaus MR, MacNeil MA, Harvey E, Simpfendorfer CA, Heupel MR, Meekan M, Wilson S, Bond ME, Speed CW, Currey-Randall LM, Fisher R, Sherman CS, Kiszka JJ, Rees MJ, Udyawer V, Flowers KI, Clementi GM, Asher J, Beaufort O, Bernard ATF, Berumen ML, Bierwagen SL, Boslogo T, Brooks EJ, Brown JJ, Buddo D, Cáceres C, Casareto S, Charloo V, Cinner JE, Clua EEG, Cochran JEM, Cook N, D'Alberto BM, de Graaf M, Dornhege-Lazaroff MC, Fanovich L, Farabaugh NF, Fernando D, Ferreira CEL, Fields CYA, Flam AL, Floros C, Fourqurean V, Barcia LG, Garla R, Gastrich K, George L, Graham R, Hagan V, Hardenstine RS, Heck SM, Heithaus P, Henderson AC, Hertler H, Hueter RE, Johnson M, Jupiter SD, Kaimuddin M, Kasana D, Kelley M, Kessel ST, Kiilu B, Kyne F, Langlois T, Lawe J, Lédée EJI, Lindfield S, Maggs JQ, Manjaji-Matsumoto BM, Marshall A, Matich P, McCombs E, McLean D, Meggs L, Moore S, Mukherji S, Murray R, Newman SJ, O'Shea OR, Osuka KE, Papastamatiou YP, Perera N, Peterson BJ, Pina-Amargós F, Ponzo A, Prasetyo A, Quamar LMS, Quinlan JR, Razafindrakoto CF, Rolim FA, Ruiz-Abierno A, Ruiz H, Samoilys MA, Sala E, Sample WR, Schärer-Umpierre M, Schoen SN, Schlaff AM, Smith ANH, Sparks L, Stoffe… See abstract for full author list ➔ Goetze JS, et al. Among authors: watts am. Nat Ecol Evol. 2024 May 20. doi: 10.1038/s41559-024-02386-9. Online ahead of print. Nat Ecol Evol. 2024. PMID: 38769434
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00548-8. doi: 10.1016/S0140-6736(24)00548-8. Online ahead of print. Lancet. 2024. PMID: 38763154 Free article.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00549-X. doi: 10.1016/S0140-6736(24)00549-X. Online ahead of print. Lancet. 2024. PMID: 38763153 Free article.
Dissecting the stability of Atezolizumab with renewable amino acid-based ionic liquids: Colloidal stability and anticancer activity under thermal stress.
Alkhawaja B, Al-Akayleh F, Al-Rubaye Z, AlDabet G, Bustami M, Smairat M, Agha ASAA, Nasereddin J, Qinna N, Michael A, Watts AG. Alkhawaja B, et al. Among authors: watts ag. Int J Biol Macromol. 2024 May 8;270(Pt 1):132208. doi: 10.1016/j.ijbiomac.2024.132208. Online ahead of print. Int J Biol Macromol. 2024. PMID: 38723835
1,337 results